|
Volumn 126, Issue 2, 2001, Pages 274-279
|
Intranasal BCG vaccination protects BALB/c mice against virulent Mycobacterium bovis and accelerates production of IFN-γ in their lungs
|
Author keywords
Immunity in the lung; Intranasal vaccination; M. bovis infection
|
Indexed keywords
BCG VACCINE;
GAMMA INTERFERON;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ARTICLE;
BACTERIAL IMMUNITY;
BACTERIAL INFECTION;
BACTERIAL VIRULENCE;
BACTERIUM ISOLATE;
BCG VACCINATION;
CONTROLLED STUDY;
CORRELATION FUNCTION;
CYTOKINE PRODUCTION;
IMMUNOREACTIVITY;
MALE;
MOUSE;
MYCOBACTERIUM BOVIS;
NONHUMAN;
PRIORITY JOURNAL;
T LYMPHOCYTE;
ADMINISTRATION, INTRANASAL;
ANIMALS;
BCG VACCINE;
CYTOKINES;
HYPERSENSITIVITY, DELAYED;
INTERFERON TYPE II;
LUNG;
LYMPHOCYTE ACTIVATION;
MALE;
MICE;
MICE, INBRED BALB C;
MYCOBACTERIUM BOVIS;
T-LYMPHOCYTES;
TUBERCULOSIS;
VIRULENCE;
|
EID: 0034782438
PISSN: 00099104
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2249.2001.01667.x Document Type: Article |
Times cited : (57)
|
References (28)
|